Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Amit Sanyal, MD: A Clinician’s Perspective

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Advertisement

Advertisement




Aug
27
Today In Oncology
WashU Medicine Appoints New Chief of Head and Neck Surgery
Colorectal Cancer May Cause Peripheral Neuropathy Before Treatment Preclinical Study Finds
Expanded EHR Data May Improve Prediction of Early Adverse Events After AML Induction Chemotherapy
Prostate Cancer NRG-GU005 Defines Trade-Offs Between SBRT and Moderately Hypofractionated IMRT
Cleveland Clinic President Discusses AI Summit for Health-Care Professionals
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo